LONG-TERM FOLLOW-UP IN PATIENTS WITH SUPERFICIAL BLADDER TUMOURS TREATED WITH INTRAVESICAL EPODYLFITZPATRICK JM; KHAN O; OLIVER RTD et al.1979; BRIT. J. UROL.; GBR; DA. 1979; VOL. 51; NO 6; PP. 545-548; BIBL. 10 REF.Article

INACTIVATION OF EPODYL^R IN ALUMINIUM FOIL CUPS AS A CAUSE OF INEFFECTIVE TREATMENT OF NON-INVASIVE BLADDER TUMOURSLARSEN J.1980; SCAND. J. UROL. NEPHROL.; ISSN 0036-5599; SWE; DA. 1980; VOL. 14; NO 3; PP. 239-242; BIBL. 11 REF.Article

PROGNOSTIC FACTORS INFLUENCING SURVIVAL OF PATIENTS RECEIVING INTRAVESICAL EPODYLRIDDLE PR; KHAN O; FITZPATRICK JM et al.1982; J. UROL.; ISSN 0022-5347; USA; DA. 1982; VOL. 127; NO 3; PP. 430-432; BIBL. 10 REF.Article

GRUNDSAETZLICHE UEBERLEGUNGEN ZUR INTENSIVEN INTRAVESIKALEN CHEMOTHERAPIE BEI OBERFLAECHLICHEM BLASEN-KARZINOM = CONSIDERATIONS FONDAMENTALES SUR LA CHIMIOTHERAPIE INTRAVESICALE INTENSIVE DANS LE CANCER VESICAL SUPERFICIELSOLOWAY MS.1981; UROLOGE, AUSG. B; ISSN 0042-1111; DEU; DA. 1981; VOL. 21; NO 5; PP. 238-239Article

TOPISCHE INTRAVESIKALE ANWENDUNG VON CHEMOTHERAPEUTIKA BEIM UEBERGANGSEPITHELTUMOR DER HARNBLASE. I: ADJUVANTE REZIDIV-CHEMOPROPHYLAXE = UTILISATION LOCALE INTRAVESICALE CHIMIOTHERAPIE DANS L'EPITHELIOMA PARAMALPIGHIEN VESICAL. I: CHIMIOPROPHYLAXIE ADJUVANTE DES RECIDIVESJACOBI GH.1979; THERAPIEWOCHE; DEU; DA. 1979; VOL. 29; NO 37; PP. 5954-5962; (7 P.); BIBL. 50 REF.Article

EPODYL^REG. TREATMENT OF BLADDER TUMOURSNIELSEN HV; THYBO E.1979; SCAND. J. UROL. NEPHROL.; SWE; DA. 1979; VOL. 13; NO 1; PP. 59-63; BIBL. 8 REF.Article

EPODYL IN MANAGEMENT OF NONINVASIVE NEOPLASMS.SMITH JM; LANE V; O'FLYNN JD et al.1978; UROLOGY; U.S.A.; DA. 1978; VOL. 11; NO 5; PP. 474-477; BIBL. 11 REF.Article

TOPISCHE INTRAVESIKALE ANWENDUNG VON CHEMOTHERAPEUTIKA BEIM UEBERGANGSEPITHELTUMOR DER HARNBLASE. II. IST EINE CHEMOTHERAPIE GERECHTFERTIGT. = APPLICATION LOCALE INTRAVESICALE POUR LA CHIMIOTHERAPIE DE L'EPITHELIOMA PARAMALPIGHIEN DE LA VESSIE. II. UNE CHIMIOTHERAPIE EST-ELLE JUSTIFIEE.JAKSE G; JACOBI GH.1981; THERAPIEWOCHE; ISSN 0040-5973; DEU; DA. 1981; VOL. 31; NO 9; PP. 1433-1440; 6 P.; BIBL. 30 REF.Article

RATIONALE FOR INTENSIVE INTRAVESICAL CHEMOTHERAPY FOR SUPERFICIAL BLADDER CANCERSOLOWAY MS.1980; J. UROL.; USA; DA. 1980; VOL. 123; NO 4; PP. 461-466; BIBL. 64 REF.Article

Adjuvant topical chemotherapy versus immunotherapy in primary superficial transitional cell carcinoma of the bladderFLAMM, J; BUCHER, A.British journal of urology (Print). 1991, Vol 67, Num 1, pp 70-73, issn 0007-1331, 4 p.Article

Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastasesSMITH, G; ELTON, R. A; CHISHOLM, G. D et al.British journal of urology (Print). 1986, Vol 58, Num 6, pp 659-663, issn 0007-1331Conference Paper

Long-term follow-up of intravesical epodyl therapy for superficial bladder cancerMUFTI, G. R; VIRDI, J. S; HALL, M. H et al.British journal of urology (Print). 1990, Vol 65, Num 1, pp 32-35, issn 0007-1331Conference Paper

Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone = Chimiothérapie adjuvante du cancer superficiel de la vessie à cellules de transition: résultats préliminaires d'un essai contrôlé comparant le chlorhydrate de doxorubicine, l'éthoglucide et l'exérèse transuréthrale seule, entrepris par l'EORTCKURTH, K. H; SCHRÖDER, F. H; TUNN, U et al.The Journal of urology. 1984, Vol 132, Num 2, pp 258-262, issn 0022-5347Article

The ultrastructure of transitional cell carcinomas of the human urinary bladder treated with ethoglucid or mitomycinSTEWART, R. J. G; LAWSON, A. H; WEAVER, J. P. A et al.The Journal of urology. 1988, Vol 139, Num 6, pp 1355-1358, issn 0022-5347Article

The role of adverse risk factors in response to epodyl treatment in superficial bladder cancerFITZPATRICK, J. M; WEST, A. B; BUTLER, M. R et al.World journal of urology (Print). 1986, Vol 4, Num 4, pp 211-214, issn 0724-4983Article

Kurzzeit-versus Langzeitchemorezidivprophylaxe mit Epodyl nach TUR beim oberflächlichen Harnblasenkarzinom = Prophylaxie brève ou prolongée des récidives par l'Epodyl après résection transurétrale du cancer vésical superficiel = Long versus short-term intravesical Epodyl chemoprophylaxis following transurethral resection of bladder tumorFLAMM, J; KUHNEL, W; DONA, S et al.Der Urologe. Ausgabe A. 1989, Vol 28, Num 2, pp 99-102, issn 0340-2592Article

Intravesical chemotherapy: studies on the relationship between pH and cytotoxicityGROOS, E; WALKER, L; MASTERS, J. R. W et al.Cancer. 1986, Vol 58, Num 6, pp 1199-1203, issn 0008-543XArticle

Topische Immuntherapie (KLH) vs. Chemotherapie (Ethoglucid) in der Rezidivprophylaxe oberflächlicher Harnblasenkarzinome. Eine prospektiv randomisierte Studie = Topical immunotherapy (KLH) vs. chemotherapy (Ethoglucid) in recurrence prophylaxis of superficial bladder carcinoma. A prospective randomized studyFLAMM, J; DONNER, G; BUCHER, A et al.Der Urologe. Ausgabe A. 1994, Vol 33, Num 2, pp 138-143, issn 0340-2592Article